PGRMC1 and cholangiocarcinoma: We observed down regulation of CCM1/2 (down in HCC), PAQR9 (up in HCC), PGRMC1/2 (up in HCC), nPRs (down in HCC), and AFP (up in HCC) in CCA primary tumors.